We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Spero Therapeutics Inc | NASDAQ:SPRO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -1.39% | 1.42 | 1.42 | 1.45 | 1.48 | 1.42 | 1.44 | 95,314 | 23:06:44 |
24th Annual H.C. Wainwright Global Investment Conference Conference Location: Lotte New York Palace Hotel, New York, NY. Presentation Format: Corporate PresentationPresentation Date & Time: Monday, September 12, 2022, at 3:30 PM ETWebcast link: https://journey.ct.events/view/d64265b3-acb7-4c51-bb98-b85beb432e2b
Webcasts of the presentations may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Investors and Media” tab. A replay of the presentations will be available on the website following the conclusion of the event.
About Spero TherapeuticsSpero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, including multi-drug resistant bacterial infections and rare diseases.
For more information, visit https://sperotherapeutics.com.
Investor Relations Contact: Ted JenkinsVice President, Investor Relations and Strategic FinanceIR@sperotherapeutics.com (617) 798-4039
Media Inquiries: media@sperotherapeutics.com
1 Year Spero Therapeutics Chart |
1 Month Spero Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions